Praktické lékárenství – 2E/2021

www.praktickelekarenstvi.cz e27 AKTUÁLNÍ FARMAKOTERAPIE Neuroprotektivní účinky statinů PRAKTICKÉ LÉKÁRENSTVÍ 24. McFarland AJ, Davey AK, McDermott CM, Grant GD, Lewohl J, Anoopkumar-Dukie S. Differences in statin associated neuroprotection corresponds with either decreased pro- duction of IL-1β or TNF-α in an in vitro model of neuroinflammation-induced neurodege- neration. Toxicol Appl Pharmacol 2018; 344: 56–73. 25. Mora S, Glynn RJ, Boekholdt SM, Nordestgaard BG, Kastelein JJ, Ridker PM. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justi- fication for the use of statins in prevention: an intervention trial evaluating rosuvastatin) J Am Coll Cardiol 2012; 59: 1521–1528. 26. Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL 2 nd , Goldstein LB, Chin C, Tan- nock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK; American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Commi- ttee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Bio- logy and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Di- sease in the Young; Council on Clinical Cardiology; and Stroke Council. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol 2019; 39(2): e38-e81. 27. Ntolkeras G, Barba C, Mavropoulos A, Vasileiadis GK, Dardiotis E, Sakkas LI, Hadjigeorgiou G, Bogdanos DP. On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells. Immunol Res 2019; 67(4–5): 310–324. 28. Quintana-Pájaro LJ, Ramos-Villegas Y, Cortecero-Sabalza E, Joaquim AF, Agrawal A, Na- rvaez-Rojas AR, Moscote-Salazar LR. The Effect of Statins in Epilepsy: A Systematic Review. J Neurosci Rural Pract 2018; 9(4): 478–486. 29. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Li- bby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359(21): 2195–207. 30. Schultz JL, Nopoulos PC, Killoran A, Kamholz JA. Statin use and delayed onset of Hun- tington's disease. Mov Disord 2019; 34(2): 281–285. 31. Tapia-Perez JH, Rupa R, Zilke R, Gehring S, Voellger B, Schneider T. Continued statin the- rapy could improve the outcome after spontaneous intracerebral hemorrhage. Neurosurg Rev 2013; 36: 279–287. 32. Tapia Perez JH, Yildiz OC, Schneider T, Nimsky C. Meta-analysis of statin use for the acute the- rapy of spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2015; 24: 2521–2526. 33. Tobert JA. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov 2003; 2(7): 517–526. 34. Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB. Statin treatment and the occu- rrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 2008; 39: 497–502. 35. Vráblík M. Farmakoterapie dyslipidemie 2. vydání, Maxdorf Praha 2016. 36. Wilson PWF, Polonsky TS, Miedema MD, Khera A, Kosinski AS, Kuvin JT. Systematic Re- view for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circula- tion 2019; 139(25): e1144–e1161. 37. Wlodarczyk J, Sullivan D, Smith M. Comparison of benefits and risks of rosuvastatin ver- sus atorvastatin from a meta-analysis of head-to-head randomized controlled trials. Am J Cardiol 2008; 102(12): 1654–1662. 38. Yan J, Qiao L, Tian J, Liu A, Wu J, Huang J, Shen M, Lai X. Effect of statins on Par- kinson's disease: A systematic review and meta-analysis. Medicine (Baltimore) 2019; 98(12): e14852. 39. Yang D, Knight RA, Han Y, Karki K, Jianfeng Z, Ding C, Chopp M, Seyfried D. Vascular re- covery promoted by atorvastatin and simvastatin after experimental intracerebral hemorr- hage: magnetic resonance imagingand histological study. J Neurosurg 2011; 114: 1135–1142.